CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
DURHAM, N.C., Sept. 20 (Korea Bizwire) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech [...]